Agile Therapeutics reported $3.42M in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Adma Biologics ADMA:US $ 114.4M 12.53M
Agile Therapeutics AGRX:US $ 3.42M 0.68M
Bayer BAYN:GR € 38019M 582M
Biomarin Pharmaceutical BMRN:US $ 4504.81M 113.49M
JAZZ PHA JAZZ:US $ 3200.78M 407.71M
Pacira Pharmaceuticals PCRX:US $ 756.64M 47.06M
Pain Therapeutics PTIE:US $ 218.37M 18.72M
Teva Pharmaceutical Industries TEVA:US $ 9037M 307M
Therapeuticsmd TXMD:US -26066000 114.51M